Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest

Familial hypercholesterolemia (FH) is a frequently undiagnosed genetic disease characterized by substantial elevations of low-density lipoprotein cholesterol (LDL-C). The prevalence of heterozygous FH (HeFH) in the general population is 1:500 inhabitants, while the prevalence of homozygous FH (HoFH)...

Full description

Bibliographic Details
Main Authors: Marco Ambrosetti, Gabriella Malfatto, Anna Maria Cremona, Marcello Arca, Pompilio Faggiano
Format: Article
Language:English
Published: PAGEPress Publications 2015-08-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/49
id doaj-4b22eb8ce678486aa7b5e2ac9e9a48e3
record_format Article
spelling doaj-4b22eb8ce678486aa7b5e2ac9e9a48e32020-11-24T22:08:07ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642015-08-0182210.4081/monaldi.2014.49Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interestMarco Ambrosetti0Gabriella Malfatto1Anna Maria Cremona2Marcello Arca3Pompilio Faggiano4UO Cardiologia e Angiologia Riabilitativa, Clinica Le Terrazze, Cunardo (VA)Cardiologia Riabilitativa, Istituto Auxologico, MilanoDegenza Breve Internistica, Ospedale di Circolo, VareseDipartimento Medicina Interna e Specialità Mediche - Centro Aterosclerosi, Sapienza Università di Roma, RomaUO Cardiologia, Spedali Civili e Università di Brescia, BresciaFamilial hypercholesterolemia (FH) is a frequently undiagnosed genetic disease characterized by substantial elevations of low-density lipoprotein cholesterol (LDL-C). The prevalence of heterozygous FH (HeFH) in the general population is 1:500 inhabitants, while the prevalence of homozygous FH (HoFH) is 1:1.000.000. If FH is not identified and aggressively treated at an early age, affected individuals have a 20-fold increased lifetime risk of coronary heart disease compared with the general population. This narrative review provide a concise overview of recommendations for diagnosis and treatment of adults and children with FH, and discuss the utility of considering FH as a comorbidity at the entry of Cardiac Rehabilitation programmes.https://www.monaldi-archives.org/index.php/macd/article/view/49familial hypercholesterolemiacardiac rehabilitationprevention
collection DOAJ
language English
format Article
sources DOAJ
author Marco Ambrosetti
Gabriella Malfatto
Anna Maria Cremona
Marcello Arca
Pompilio Faggiano
spellingShingle Marco Ambrosetti
Gabriella Malfatto
Anna Maria Cremona
Marcello Arca
Pompilio Faggiano
Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
Monaldi Archives for Chest Disease
familial hypercholesterolemia
cardiac rehabilitation
prevention
author_facet Marco Ambrosetti
Gabriella Malfatto
Anna Maria Cremona
Marcello Arca
Pompilio Faggiano
author_sort Marco Ambrosetti
title Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
title_short Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
title_full Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
title_fullStr Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
title_full_unstemmed Familial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
title_sort familial hypercholesterolemia in cardiac rehabilitation: a new field of interest
publisher PAGEPress Publications
series Monaldi Archives for Chest Disease
issn 1122-0643
2532-5264
publishDate 2015-08-01
description Familial hypercholesterolemia (FH) is a frequently undiagnosed genetic disease characterized by substantial elevations of low-density lipoprotein cholesterol (LDL-C). The prevalence of heterozygous FH (HeFH) in the general population is 1:500 inhabitants, while the prevalence of homozygous FH (HoFH) is 1:1.000.000. If FH is not identified and aggressively treated at an early age, affected individuals have a 20-fold increased lifetime risk of coronary heart disease compared with the general population. This narrative review provide a concise overview of recommendations for diagnosis and treatment of adults and children with FH, and discuss the utility of considering FH as a comorbidity at the entry of Cardiac Rehabilitation programmes.
topic familial hypercholesterolemia
cardiac rehabilitation
prevention
url https://www.monaldi-archives.org/index.php/macd/article/view/49
work_keys_str_mv AT marcoambrosetti familialhypercholesterolemiaincardiacrehabilitationanewfieldofinterest
AT gabriellamalfatto familialhypercholesterolemiaincardiacrehabilitationanewfieldofinterest
AT annamariacremona familialhypercholesterolemiaincardiacrehabilitationanewfieldofinterest
AT marcelloarca familialhypercholesterolemiaincardiacrehabilitationanewfieldofinterest
AT pompiliofaggiano familialhypercholesterolemiaincardiacrehabilitationanewfieldofinterest
_version_ 1725817724499656704